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Abstract
The aim of this article is to describe the surgical tech-
niques for the treatment of hilar cholangiocarcinoma 
(HC). Resection with microscopically negative margin 
(R0) is the only way to cure patients with HC. Today, 
resection of the caudate lobe and part of segment Ⅳ, 
combined with a right or left hepatectomy, bile duct 
resection, lymphadenectomy of the hepatic hilum and 
sometimes vascular resection, is the standard surgical 
procedure for HC. Intraoperative frozen-section exami-
nation of proximal and distal biliary margins is neces-
sary to confirm the suitability of resection. Although 
lymphadenectomy probably has little direct effect on 
survival, inaccurate staging information may influence 
post resection treatment recommendations. Aggressive 
venous and arterial resections should be undertaken in 
selected cases to achieve a R0 resection. The concept 
of “no-touch proposed” in 1999 by Neuhaus et al  com-
bine an extended right hepatectomy with systematic 
portal vein resection and caudate lobectomy avoiding 
hilar dissection and possible intraoperative microscopic 
dissemination of cancer cells. More recently minor liver 
resections have been proposed for treatment of HC. 
As the hilar bifurcation of the bile ducts is near to liver 
segments Ⅳ, Ⅴ and Ⅰ, adequate liver resection of 
these segments together with the bile ducts can result 
in cure.
© 2013 Baishideng. All rights reserved.
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Core tip: The aim of this article is to describe the surgi-
cal techniques for the treatment of hilar cholangiocar-
cinoma (HC). In recent years, parenchyma-preserving 
hepatic resections have been proposed to treat high 
risk surgical patients without vascular infiltration. This 
type of liver resection must include segments Ⅰ, Ⅳb 
and Ⅴ. Radical surgery in patients with type Ⅰ or Ⅱ tu-
mors should also include a right liver resection, except 
in the case of papillary HC and in high-risk surgical pa-
tients.
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INTRODUCTION
The aim of  this article is to describe and discuss aspects 
of  the surgical techniques used in the treatment of  hilar 
cholangiocarcinoma (HC). No exhaustive survey of  the 
results obtained by surgery will be made; this question is 
addressed in a separate section.
As is the case with the surgical treatment of  other 
tumor diseases, the improvements introduced in recent 
decades have derived not from evidence obtained in clinical 
trials but from a better understanding of  the pathways of  
tumor spread[1-11]. Furthermore, most of  the publications 
on this subject are studies comparing the results in recent 
cohorts with historical data. Due to the rarity of  HC, most 
surgical series have a long inclusion period[12,13]. As a result, 
changes in perioperative management techniques over the 
course of  a study can introduce bias. All these features have 
complicated and delayed the introduction of  new tech-
niques and strategies in the surgical treatment of  HC.
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HC surgery remains one of  the most technically chal-
lenging operations for hepatobiliary surgeons, due to the 
complex, intimate, and sometimes variable anatomical 
relations of  the bile duct and vascular structures. Radical 
resection with a microscopically negative margin (R0) is 
the only way to cure patients with HC and is associated 
with marked survival advantages compared to margin-
positive resections. Unfortunately, only 50%-70% of  
patients who undergo surgery are candidates for curative 
resection[14]. Over the last decades, various technical in-
novations have been introduced in order to increase the 
chances of  achieving a negative resection margin, which 
is the only prognostic factor under the control of  the 
surgeon. Today, resection of  the caudate lobe and part 
of  Couinaud’s segment Ⅳ, combined with a right or left 
hepatectomy, bile duct resection, lymphadenectomy of  
the hepatic hilum and sometimes vascular resection, is 
the standard surgical procedure for HC. 
In the early 1970s, Longmire[15] introduced the con-
cept of  partial hepatectomy in resection of  HC. Howev-
er, because of  the poor postoperative outcomes, hepatic 
resection was not recommended during the two following 
decades. Starting in the 1990s, more partial liver resec-
tions were performed for HC and were routinely com-
bined with complete excision of  the caudate lobe which 
is now fully accepted[16-22]. Likewise, better outcomes 
were reported with more radical surgery. The Memorial 
Sloan-Kettering group found that a concomitant hepa-
tectomy resulted in an R0 resection in 78% of  the pa-
tients and it was the only independent predictor of  long-
term survival[14]. Today the reported resectability rate 
ranges between 28% and 95% and the radical resection 
rate varies from 14% to 95%[23-27].
Over this period, Japanese surgeons have adopted a 
more aggressive approach and have achieved a higher 
negative margin resection rate[28]. They have also pub-
lished numerous “tricks” to increase the chances of  
achieving radical resection. 
LAPAROSCOPIC ASSESSMENT
The goal of  staging laparoscopy is to exclude peritoneal 
metastases and small liver metastases, for which other 
noninvasive tests lack accuracy. van Gulik et al[29] re-
ported that laparoscopy avoided unnecessary laparotomy 
in 25%-40% of  patients. However, the use of  staging or 
preoperative laparoscopy for HC is not widely accepted. 
Regimbeau et al[30] observed that laparoscopic assessment 
was not routinely performed in France in 2008 and that 
the accuracy of  this procedure even in selected patients 
appeared to be low. That series included 56 patients and 
only in one case was resection contraindicated due to 
peritoneal carcinomatosis. More recently, Ruys et al[31] 
evaluated the benefit of  laparoscopic assessment in 195 
patients treated from 2000 to 2010. They found that the 
yield and accuracy of  laparoscopy were considerably 
lower than those reported in previous studies including 
one performed by their own team. Laparoscopy avoided 
unnecessary laparotomy in only 14% of  patients, with an 
accuracy of  32%.
Explanations for these changes are the impact of  
new imaging techniques and a better selection of  pa-
tients for laparoscopy. After their review, the authors 
recommended that laparoscopy should be performed 
only in patients with Bismuth type Ⅲ and Ⅳ and that it 
should be used preceding laparotomy in a single session.
INTRAOPERATIVE BIOPSIES OF BILIARY 
MARGIN
Intraoperative frozen-section examination of  proximal 
and distal biliary margins is necessary to confirm the 
suitability of  resection. If  invasive cancer is observed in 
the examination, additional resection is recommended to 
complete tumor removal[24,32]. However, additional resec-
tion of  a positive proximal bile duct is difficult, and, usu-
ally, only a few extra millimeters can be resected. Some 
evidence has suggested that this additional resection of  
the proximal bile duct margin does not confer any sur-
vival advantage[33]. However, Ribero et al[34] found that 
median survival after additional resection of  an intraop-
erative proximal bile duct margin was similar to that ob-
served after primary R0 resections (30.6 vs 29.3). There-
fore, although the available evidence is inconsistent, it 
seems advisable to try to complete resection whenever 
possible. On the other hand, this additional resection is 
associated with increasing incidence of  postoperative 
biliary fistula. Finally, it should be borne in mind that in-
traoperative frozen section analysis of  proximal bile duct 
margin is misleading in 9% patients.
LYMPHADENECTOMY
Lymphadenectomy associated with resection of  HC 
must include lymph nodes, lymphatic channels and 
nerves surrounding the portal vein and hepatic artery. 
Nodal invasion beyond the hepatoduodenal ligament, in-
cluding para-aortic nodal metastases, has a dismal prog-
nosis with a 5-year survival of  0%-12%[35,36]. Therefore, 
routine lymph node dissection beyond the hepatoduo-
denal ligament is not generally recommended[36,37]. Once 
HC has metastasized to lymph nodes, an extended nodal 
dissection can provide a more accurate staging of  the 
disease, but cannot improve survival.
The intraoperative finding of  lymph node metasta-
ses is not considered a reason for abandoning resection 
when lymph node metastases are confined to the hepatic 
pedicle or the hepatoduodenal ligament[29]. However, 
tumor positive lymph nodes along the common hepatic 
artery or celiac axis are usually considered a contraindi-
cation for resection.
Lymphadenectomy for HC is unlikely to provide any 
great clinical benefit. Recently, Kitagawa et al[35] analysed 
110 patients with HC who underwent both regional and 
para-aortic lymphadenectomy. A median of  24 lymph 
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nodes were retrieved during surgery. The disease-specific 
survival of  patients with para-aortic lymph node metas-
tasis was similar to M1 patients, suggesting that survival 
is not influenced by the extent of  lymphadenectomy but 
rather by the presence of  metastatic disease. However 
the Nagoya group[35] reported the 5-year survival for 
patients with para-aortic nodal metastases to be 12.3%. 
The finding that long-term survival is possible in pa-
tients with para-aortic disease encouraged the authors to 
perform aggressive surgery with extended lymph node 
dissection in selected patients.
Some authors have reported changes in the extent 
of  lymphadenectomy in successive historical periods. In 
the initial period[38] lymphadenectomy was regional. It 
was then extended to include para-aortic nodes from the 
level of  the diaphragm to aortic bifurcation, but this was 
associated with high morbidity. Finally lymphadenec-
tomy was reduced to include the para-aortic nodes from 
the level of  the coeliac axis to the mesenteric inferior 
vein. However, in the elderly (> 70 years) lymphadenec-
tomy was limited to regional nodes in order to reduce 
perioperative mortality.
Although lymphadenectomy probably has little direct 
effect on survival, inaccurate staging information may 
influence post resection treatment recommendations 
which in turn have the potential to affect outcome. The 
studies by the Memorial Sloan-Kettering Center[39,40] sug-
gest that a minimum of  seven lymph nodes are needed 
in the surgical specimen to obtain a correct staging.
VASCULAR RESECTIONS
The role of  portal vein resection (PVR) is controver-
sial. Although portal vein bifurcation invasion used to 
be considered a relative contraindication for resection, 
more recently some surgeons have advocated a more 
aggressive approach[41]. Despite recent advances in di-
agnostic imaging techniques, portal vein invasion is still 
a relatively frequent intraoperative finding. Surgeons 
should suspect the presence of  this invasion if  they find 
severe adhesions between the tumor and the portal vein 
bifurcation. In this situation, combined resection and 
reconstruction of  the portal vein is necessary to obtain a 
negative surgical margin.
de Jong et al[41] recently published the results of  an 
international, multicenter database from seven major 
hepatobiliary centers. They found that 30-d postopera-
tive mortality was higher in the cohort of  patients who 
underwent concomitant PVR (17.6% vs 10.6%, P = 0.03). 
However, no differences in long-term outcome were 
observed compared to patients who underwent hepatec-
tomy without vein resection. The authors conclude that 
PVR should be undertaken when necessary to extirpate 
all disease. 
Nagino[42] recommend PVR only when the vessel 
adheres to and cannot be freed from the tumor during 
skeletonization resection of  the hepatoduodenal liga-
ment. In contrast, Neuhaus et al[43] recommend routine 
resection of  the portal vein to achieve more radical 
surgery. This latter strategy will be discussed in another 
section. However, there are no randomized studies to 
support it.
Advances in surgical technique have facilitated the 
performance of  hepatic artery resection and reconstruc-
tion during surgical treatment of  HC. However, most 
of  the studies[44-46] have shown negative results and do 
not recommend a combined resection of  the hepatic 
artery for biliary cancer. However, in 2010, Igami et al[47] 
reported their experience with major hepatectomies with 
resection and reconstruction of  the hepatic artery. In 
this series of  53 patients (18%) undergoing concomitant 
hepatic artery resection with or without PVR, only one 
patient died in the postoperative period and two sur-
vived more than five years after surgery. 
EXTENDED HEPATECTOMY FOR HC: 
NO-TOUCH CONCEPT
Extended right hemihepatectomy consists of  the re-
section of  the right liver, the inferior part of  segment 
Ⅳ, the hilar plate, and the entire caudate lobe[48], while 
extended left hemihepatectomy consists of  resection 
of  the left liver, the hilar plate of  the right paramedian 
sector, and most of  the caudate lobe. Both are coupled 
with complete resection of  the extrahepatic bile duct 
and porta hepatis lymphadenectomy. The choice of  
side is dependent on the predominance of  the tumor, 
but an extended right-hemihepatectomy is indicated for 
centrally located tumors, because of  the length of  each 
hepatic duct, the location of  the hilar common bile duct 
in the hepatoduodenal ligament, the ease of  complete 
caudate lobectomy and portal vein reconstruction, and 
the frequent involvement of  the right hepatic artery[9,32].
“No-touch” concept
Usually, resection of  the portal vein is carried out when 
the vein is adherent to the tumor and cannot be freed. 
However, even in cases where negative margins are pro-
ven histologically, local or peritoneal recurrence may 
occur during the follow-up period. One possible reason 
for recurrence is the microscopic dissemination of  can-
cer cells during dissection of  the portal vein in the hilar 
region, where the bile duct involved lies very close to the 
portal vein. In fact, the distance between the tumor and 
the outer layer of  the adventitia of  the portal vein is less 
than 1 mm, even in cases without portal infiltration[6]. 
What is more, the majority of  hilar malignancies have 
microscopic perineural infiltration of  the tumor.
Ebata et al[6] reported that the intraoperative mac-
roscopic diagnosis of  portal infiltration, regardless of  
microscopic diagnosis, was a significant prognostic fac-
tor. This result probably confirms that exposure of  the 
tumor may occur during portal dissection, even in a case 
without microscopic infiltration. In the operative field 
microscopic invasion cannot be distinguished from ad-
hesion and perivascular fibrosis[49].
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The concept of  no-touch was proposed in 1999 by 
Neuhaus et al[50] as a result of  a multivariate analysis of  
prognostic factors in 100 resected patients. Surgical radi-
cality, lymphangiosis carcinomatosa, perineural sheath 
infiltration and histopathological grading were identified 
as independent prognostic variables for the entire group 
of  patients. However, in patients with curative resec-
tion, the only independent prognostic variable was an 
additional resection of  the portal vein bifurcation. After 
this, the authors decided to apply the principles of  no-
touch techniques to HC and combined an extended right 
hepatectomy with PVR and caudate lobectomy. This 
technique avoids the dissection of  the right hepatic ar-
tery, which can easily be infiltrated by tumor, and obtains 
a wide tumor-free biliary margin, since the left hepatic 
duct measures up to 5 cm. 
The goal of  a no-touch technique and an en bloc re-
section can be achieved by placing vascular clamps on 
the left portal vein branch within the umbilical fissure as 
well as on the portal vein trunk, directly above the pan-
creatic head, and dividing the two vessels without dis-
secting the portal vein bifurcation. This strategy is facili-
tated by the anatomical characteristics of  the left portal 
vein which runs transversely from the bifurcation to the 
umbilical portion. After this, an end-to-end venous anas-
tomosis is performed. This reconstruction straightens 
the portal vein, avoiding the kinking frequently observed 
after right hepatic resections. Depending on the extent 
of  tumor growth to the left, it may be impossible to 
keep the whole of  segment IV. This increases the risk of  
postoperative liver insufficiency, but reduces the number 
of  biliary orifices to anastomose.
In 2012, Neuhaus et al[43] compared the oncological 
results of  hilar en bloc resection to that of  major hepatec-
tomy. The 5-year survival of  patients who underwent en 
bloc resection was significantly superior (58% vs 29%, P = 
0.021).
LEFT RESECTIONS
Right or extended right hepatectomy is not indicated 
in cases of  HC extending far to the left, with atrophy 
of  segments Ⅱ and Ⅲ and with vascular complications 
in the left hemiliver. In these situations left resections 
are indicated and represent about 25%-30% of  all re-
sections. Left hepatectomy is considered to be a more 
complicated procedure, than right hepatectomy[8,51] and 
requires greater skill, especially in cases involving PVR 
and reconstruction. Resecting the portal vein bifurcation 
when performing a left trisectionectomy is substantially 
more difficult because of  the relatively short course of  
the right portal vein before branching. Surgical resection 
for Bismuth-Corlette type Ⅲb tumor with involvement 
of  the portal vein bifurcation may not be feasible even 
in specialized centers because of  the difficulty of  portal 
vein reconstruction. 
The distance from the principal biliary bifurcation 
to the sectional ramification in the right liver is much 
shorter than in the left[52]. Furthermore, there are many 
anatomical variations in the right sectional bile ducts[53]. 
These anatomical issues may increase the difficulty of  
achieving tumor-free stumps for right sectional ducts 
during left hepatectomy compared with right hepatecto-
my. Furthermore, the presence of  more complex biliary 
anastomoses increases the risk of  postoperative biliary 
leakage.
Another oncological problem with left or left-extend-
ed hepatectomy is the need to preserve the right hepatic 
artery and the right portal vein, which increases the risk 
of  tumor cell dissemination. 
To confirm whether a predominantly left-sided tumor 
is resectable with a left trisectionectomy, the surgeon can 
apply a combination of  manual palpation, intraoperative 
ultrasound and dissection along the posterior aspect of  
the right portal pedicle. These maneuvers could help to 
determine whether the tumor has extended to the pos-
terior division of  the right pedicle[54]. Lowering the hilar 
plate would be very useful in this exploration, because 
the division occurs intrahepatically; however, this dissec-
tion would be too close to the boundaries of  the tumor 
and is not recommended.
If  the right hepatic artery is infiltrated by the tumor, 
it must be resected en bloc to achieve a radial R0 resec-
tion. In this situation reconstruction of  the right hepatic 
artery is difficult and the risk of  technical failure is high. 
Based on the knowledge of  spontaneous arterial re-
vascularization of  the liver after ligation of  the proper 
hepatic artery, it has been proposed that pre-operative 
embolization of  the proper hepatic artery induces devel-
opment of  arterial collaterals through the hepatic liga-
ments, providing additional arterial supply to the liver. 
This will facilitate the performance of  a R0 resection, as 
the proper, left and right hepatic arteries could be totally 
resected without vascular anastomosis. 
Yasuda et al[55] reported the preoperative arterial em-
bolization of  the proper hepatic artery in six patients. In 
all patients, arterial flow signals were detected in the liver 
with Doppler ultrasonography. Three weeks after em-
bolization, surgery was performed and in all cases a R0 
resection was achieved. During surgery, intraoperative 
Doppler ultrasonography confirmed collateral arterial 
blood flow in the right anterior and posterior segmental 
branches of  the right hepatic artery. During dissection 
of  the hepatoduodenal ligament, the bile duct can be 
dissected in the right liver without risk of  injury to ac-
companying arterial branches. However, mobilization of  
the right liver or division of  ligaments must be avoided 
to preserve arterial revascularization.
In the study by Shimizu et al[56] R0 resection was 
achieved in all seven patients who underwent right tri-
sectionectomy, but in only eight of  13 patients (61.5%) 
undergoing left trisectionectomy. This suggests that a 
more extended resection from the right side, but not 
from the left, may provide greater potential for cure.
Some authors[57] consider that extended left hepatec-
tomy increases the extent of  resection in the periphery 
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of  the liver, but that the oncological benefit in the peri-
hilar region is very limited. However Nagino[42] reported 
that left trisectionectomy increased the number of  nega-
tive proximal ductal margins compared with left hepa-
tectomy, leading to a high proportion of  R0 resections, 
and improving survival for patients with advanced left-
sided perihilar cholangiocarcinomas[58]. Therefore, these 
authors recommend left trisectionectomy in such cases, 
even if  the tumor is deemed to be resectable by left 
hepatectomy.
Despite the difficulties associated with left liver resec-
tions, no other treatments achieve survival rates com-
parable to those of  surgical resection. Therefore left or 
extended left hepatectomy should be aggressively per-
formed for type Ⅲb tumor if  curative resection is pos-
sible, even in cases with portal involvement.
STRATEGY WITH BISMUTH TYPE Ⅰ 
AND Ⅱ PATIENTS
Some authors[12,14,27] have considered that patients with 
Bismuth type Ⅰ or Ⅱ tumors can be treated with local or 
hilar resections including the extrahepatic suprapancre-
atic biliary tract. However, others[10] have recommended 
a left hepatectomy, because this procedure affords high 
resectablity, is safe and provides good quality of  postop-
erative life. Finally, others[13,32] support the indication of  a 
right hepatectomy because the right hepatic artery passes 
behind the common hepatic duct and, therefore, can be 
infiltrated by cancer. 
Bismuth type Ⅰ and Ⅱ HCs appear less advanced on 
cholangiography and are easier to resect than Bismuth 
type Ⅲ and Ⅳ tumors. Therefore hilar resection is the 
procedure preferred by many surgeons. However, loco-
regional recurrence may be frequent[12,15] even after R0 
resections. Moreover, Seyama et al[26] reported better prog-
nosis in patients with Bismuth type Ⅰ and Ⅱ tumors who 
underwent right hepatectomy with caudate lobectomy. 
Histologic evaluation of  the right hepatic artery showed 
that its infiltration is infrequent, but the distance be-
tween the edge of  the cancer and the arterial adventitia 
was very short (1 mm in many cases). Therefore without 
right hepatectomy the resection margin could have been 
positive.
In the opinion of  Ikeyama et al[59] the surgical ap-
proach to Bismuth type Ⅰ and Ⅱ HCs should be based 
on the macroscopic tumor type seen in the preoperative 
study. For nodular and infiltrating HCs, right hepatec-
tomy offers the best long-term survival, whereas for 
papillary tumor bile duct resection with or without lim-
ited hepatectomy is adequate unless spread of  superficial 
cancer is discovered preoperatively.
PARENCHYMA PRESERVING SURGERY
A reduction in morbidity and mortality after liver resec-
tion is the key strategy for improving the results of  sur-
gical treatment of  HC.
Minor liver resection (three segments or fewer, ac-
cording to the Couinaud nomenclature) may be one way 
to resolve the problem of  the high mortality after major 
liver resections. As the hilar bifurcation of  the bile ducts 
is near to liver segments Ⅳ, Ⅴ and Ⅰ, adequate liver 
resection of  these segments together with the bile ducts 
can result in cure. For early tumor stage, minor resec-
tion of  segments Ⅰ, Ⅳb and Ⅴ has been performed to 
excise the tumor with adequate margins; this is termed 
“central liver resection” by some authors[60]. 
A central hepatectomy for HC can preserve up to 
35% more functional liver parenchyma than an extended 
hepatectomy. However, it has not been widely accepted 
as an alternative to extended hepatectomy because of  its 
uncertain oncological equivalence and greater technical 
complexity[61,62].
The study by Chen et al[63] did not find differences in 
cumulative survival rates between major and minor liver 
resection in patients with HC. Furthermore, major liver 
resection was associated with higher operative mortality 
and morbidity rates than minor resection. Chen at al[63] 
hold that major resections should be reserved for Bis-
muth-Corlette type Ⅲ HC with vascular invasion, or type 
Ⅳ HC. In central liver resection for HC, many intrahe-
patic bile ductal openings are left behind, making the re-
construction very difficult; this is the main disadvantage 
of  this procedure. However, using their own technique 
of  hepatojejunal anastomosis the same authors reported 
a bile leak rate of  only 14%[63].
OTHER SURGICAL “TRICKS”
Resection of middle hepatic artery in right hepatectomy
Frequently, the middle hepatic artery (MHA) runs in 
close proximity to the HC. In this case, preservation of  
this artery in a right hepatectomy may result in a positive 
resection margin. On the other hand, interruption of  
the arterial flow could cause postoperative complications 
related to biliary ischemia such as the disruption of  the 
bilioenteric anastomosis and liver abscess. 
A retrospective study by Hirano et al[64] investigated 
the anatomical variations of  the MHA and also assessed 
the safety of  resection of  the MHA combined with right 
hepatectomy, caudate lobectomy, and bile duct resection. 
In this study of  61 patients with hilar biliary malignan-
cies, the perioperative outcomes in patients in whom the 
MHA was resected were similar to those in whom it was 
preserved.
Anatomic study of  the microcirculation of  the liver 
revealed that the intrahepatic bile ducts are fed by a 
dense surrounding vascular plexus arising from the he-
patic artery[65]. After a right hepatectomy, the peribiliary 
plexuses of  the bile ducts from the left medial and lateral 
sections may retain their connections through the plate 
system, compensating for any loss of  arterial blood sup-
ply. Compensatory arterial blood supply to the area fed 
by the interrupted artery may also derive from intrahe-
patic interconnecting arterial pathways or vessels con-
necting the hepatic artery and the portal system. 
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Portal vein arterialization
PVA has been used in patients with portal hyperten-
sion, liver transplantation and acute liver failure to solve 
the occlusion of  the hepatic artery. In the context of  
HC this procedure can be used to allow radical resec-
tion in patients requiring an extended left hepatectomy 
who present encasement of  the right hepatic artery[66]. 
The encasement of  the hepatic artery can prevent its 
resection and anastomoses. The objective of  the PVA is 
to ensure adequate oxygen delivery to hepatocytes and 
biliary ducts. Animal experiments have suggested that 
PVA can improve the microcirculation in the liver, but a 
sustained increase in portal pressure can promote hepa-
tocyte apoptosis and inhibit liver regeneration[67]. Anas-
tomoses with small arteries (< 3 mm) should reduce the 
risk of  severe portal hypertension. PVA can be consid-
ered a salvage procedure in special situations[68], but has 
some drawbacks that limit its indications.
CONCLUSION
The goal of  surgical treatment of  HC should be an R0 
resection. The planning of  surgery should take into ac-
count the difficulties in establishing tumor boundaries 
intraoperatively and the close proximity to certain ana-
tomical structures such as the caudate lobe and the right 
hepatic artery. Therefore, potentially radical intervention 
should include resection of  the bile duct with lymphad-
enectomy of  the hepatic hilum and right hepatectomy in-
cluding the caudate lobe and part of  segment Ⅳb. There 
is evidence that systematic resection of  the portal bifur-
cation can decrease the risk of  loco-regional recurrence. 
However, not all authors agree on this point. 
When the HC mainly involves the left liver (Ⅲb type) a 
left or left-extended hepatectomy should be performed. 
These interventions are technically more difficult and 
potentially less radical. In selected patients, resection and 
reconstruction of  the right hepatic artery may offer the 
possibility of  radical surgery in patients with tumors that 
mainly affect the left liver. Portal arterialization may be a 
salvage procedure in these patients when resection and 
reconstruction of  the right hepatic artery is not possible.
In recent years, parenchyma-preserving hepatic re-
sections have been proposed to treat high risk surgical 
patients without vascular infiltration. This type of  liver 
resection must include segments Ⅰ, Ⅳb and Ⅴ. Radical 
surgery in patients with type Ⅰ or Ⅱ tumors should also 
include a right liver resection, except in the case of  papil-
lary HC and in high-risk surgical patients.
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